Coinbase and MicroStrategy both reported ugly Q1 numbers amid a brutal bitcoin drawdown, but the reasons behind each loss reveal a fundamental split in how these companies are built to survive a crypto winter.
The SPDR S&P Semiconductor ETF (NYSEARCA:XSD) and the VanEck Semiconductor ETF (NASDAQ:SMH) both offer exposure to semiconductors, yet they are two very different bets. XSD spreads chips money almost evenly across roughly 40 U.S.…
A Korean memory giant just pulled off the biggest foreign U.S. listing ever and blew past the year's most hyped debut on its first morning of trading, leaving investors to decide whether the AI…
The choice between iShares 20+ Year Treasury Bond ETF (NASDAQ:TLT) and iShares 7-10 Year Treasury Bond ETF (NASDAQ:IEF) looks trivial on paper. Both hold only U.S. Treasuries, both charge 0.15%, and both pay monthly.…
Japan's Finance Minister just urged the world's largest pension fund to redirect its money, and even a small shift in its carefully balanced portfolio could send shockwaves through currency and bond markets that investors…
Microsoft shares have shed nearly 20% this year while Azure accelerates and contracted future revenue sits at a jaw-dropping figure that dwarfs the concerns dragging the stock down. Something in that equation does not…
Meta just signed a $21 billion deal with CoreWeave while quietly building the infrastructure to make that deal unnecessary. Here is what happens to CoreWeave shareholders if Zuckerberg stops renting and starts competing.
NVIDIA just handed investors a revenue guidance figure so large it strains credibility, and the most striking part is what the company deliberately left out of that number.
Six tech giants have flooded the corporate bond market with a level of borrowing that dwarfs anything seen in recent memory, and the bet only pays off if AI delivers returns at a scale…
Backpack's CEO just went on CNBC to announce something no crypto brokerage has pulled off before, and the opening lineup of stocks hints at exactly where international capital wants to flow next.
Moderna, ImmunityBio, and Sarepta are all cratering today despite bullish recent news and no negative catalysts in sight, leaving investors scrambling to understand whether the biotech sector's monster 2026 run has finally hit a…
Tesla just posted its biggest Q2 delivery number ever, but the stock dropped sharply anyway, and the real question investors are now asking has nothing to do with cars.
Stifel just blew past Wall Street's AMD consensus with a target that would push the chipmaker into trillion-dollar territory, and the conditions required to get there are more specific than most investors realize.
Meta keeps beating on revenue and margins while its stock sits well below last year's peak, and the gap between operational strength and share price performance raises a question most investors are getting wrong…
SK Hynix just shattered a decades-old US listing record, and Bloomberg's desk thinks it signals something much bigger than one blockbuster IPO for the companies already supplying the AI buildout.
